Sexual dysfunction associated with antidepressant drugs

Expert Opinion on Drug Safety

Volumn 3, Issue 5, 2004, Pages 457-470

  Baldwin, David S ^a  

^a ROYAL SOUTH HANTS HOSPITAL   (United Kingdom)

Author keywords

Antidepressants; Bupropion; Mirtazapine; Moclobemide; Monoamine oxidase inhibitors (MAOIs); Nefazodone; Reboxetine; Selective serotonin re uptake inhibitors (SSRIs); Sexual dysfuntion; Tricyclic antidepressants (TCAs)

Indexed keywords

AMANTADINE; AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BUSPIRONE; CITALOPRAM; CYPROHEPTADINE; DEXAMPHETAMINE; DOXEPIN; FLUOXETINE; GINKGO BILOBA EXTRACT; GRANISETRON; IMIPRAMINE; MAPROTILINE; MIANSERIN; MIRTAZAPINE; MOCLOBEMIDE; NEFAZODONE; NEOSTIGMINE; OLANZAPINE; PAROXETINE; PHENELZINE; PLACEBO; PROSTAGLANDIN E; REBOXETINE; SEROTONIN 2 ANTAGONIST; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; SILDENAFIL; UNINDEXED DRUG;

ACCURACY; ADJUVANT THERAPY; ANORGASMIA; BEHAVIOR THERAPY; BODY WEIGHT DISORDER; CLINICAL STUDY; CLINICAL TRIAL; COMMUNITY; CONVALESCENCE; DISEASE ASSOCIATION; DISTRESS SYNDROME; DROWSINESS; DRUG DOSE REDUCTION; DRUG DOSE REGIMEN; DRUG HALF LIFE; DRUG MECHANISM; DRUG USE; DRUG WITHDRAWAL; EPIDEMIOLOGICAL DATA; HUMAN; HUMAN RELATION; INCIDENCE; IRRITABILITY; LIBIDO DISORDER; METHODOLOGY; ORGASM DISORDER; PATIENT CARE; POPULATION RESEARCH; PREMATURE EJACULATION; PSYCHOSOMATIC DISORDER; PSYCHOTHERAPY; RECURRENT DISEASE; REVIEW; SEDATION; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; SEXUAL FUNCTION; SIDE EFFECT; WEIGHT GAIN;

ADOLESCENT; ADULT; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; CROSS-OVER STUDIES; DEPRESSION; DEPRESSIVE DISORDER; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; EJACULATION; FEMALE; HUMANS; IMPOTENCE; LIBIDO; MALE; ORGASM; PHYTOTHERAPY; PREVALENCE; PROSPECTIVE STUDIES; RANDOMIZED CONTROLLED TRIALS; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION, PHYSIOLOGICAL;

EID: 4544274763     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740338.3.5.457     Document Type: Review

References (96)

1. WORLD HEALTH ORGANIZATION: The ICD-10 Classification of Mental and Behavioural Disorders. Geneva. World Health Organization (1992).
2. AMERICAN PSYCHIATRIC ASSOCIATION: Diagnostic and Statistical Manual of Mental Disorders (4th edn). American Psychiatric Association, Washington (1994).
3. HART G, WELLINGS K: Sexual behaviour and its medicalisation: in sickness and in health. Br. Med. J. (2002) 324:896-900.
4. MOYNIHAN R: The making of a disease: female sexual dysfunction. Br. Med. J. (2003) 326:45.
5. BASSON R, LEIBLUM S, BROTTO L et al.: Definitions of women's sexual dysfunction reconsidered: advocating expansion and revision. J. Psychosom. Obstet. Gynaecol. (2003) 24:221-229.
6. BALDWIN DS: Antidepressant drugs and sexual dysfunction. University of Southampton. DM thesis (2004).
7. SIMONS JS, CAREY MP: Prevalence of sexual dysfunctions: results from a decade of research. Arch. Sex. Behav. (2001) 30:177-219.
8. DUNN KM, JORDAN K, CROFT PR, ASSENDELFT WJ: Systematic review of sexual problems: epidemiology and methodology. J. Sex Marital Ther. (2002) 28:399-422.
9. BALDWIN DS: Depression and sexual dysfunction. Br. Med. Bull. (2001) 57:81-99.
10. HAMILTON M: A rating scale for depression. J. Neurol. Neurosurg. Pychiatr. (1960) 23:56-62.
11. SCHREINER-ENGEL P, SCHIAVI RC: Lifetime psychopathology in individuals with low sexual desire. J. Nerv. Ment. Dis. (1986) 174:646-651.
12. KIVELA SL, PAHKALA K: Clinician-rated symptoms and signs of depression in aged Finns. Int. J. Soc. Pychiatr. (1988) 34:274-284.
13. ANGST J: Sexual problems in healthy and depressed patients. Int. Clin. Psychopharmacol. (1998) 13:S1-S3.
14. CASPER RC, REDMOND E, KATZ MM, SCHAFFER CB, DAVIS JM, KOSLOW SH: Somatic symptoms in primary affective disorders: presence and relationship to the classification of depression. Arch. Gen. Psychiatry (1985) 42:1098-1104.
15. KOCKOTT G, PFEIFFER W: Sexual disorders in nonacute psychiatric out-patients. Compr. Psychiatry (1996) 37:56-61.
16. REYNOLDS CF III, FRANK E, THASE ME et al.: Assessment of sexual function in depressed, impotent, and healthy men: factor analysis of a Brief Sexual Function Questionnaire for men. Psychiatry Res. (1988) 24:231-250.
17. MATHEW RJ, WEINMAN ML: Sexual dysfunctions in depression. Arch. Sex. Behav. (1982) 11:323-325.
18. NOFZINGER EA, THASE ME, REYNOLDS CF III: Sexual function in depressed men. Assessment by self-report, behavioural, and nocturnal penile tumescence measures before and after treatment with cognitive behavior therapy. Arch. Gen. Psychiatry (1993) 50:24-30.
19. MONGOMERY SA, BALDWIN DS, RILEY A: Antidepressant medications: a review of the evidence for drug-induced sexual dysfunction. J. Affect. Disord. (2002) 69:119-140.
20. DAKER-WHITE G: Reliable and valid self-report outcome measures in sexual (dys)function: a systematic review. Arch. Sex. Behav. (2002) 31:197-209.
21. HARRISON WM, RABKIN JG, EHRHARDT AA et al.: Effects of antidepressant medication on sexual function: a controlled study. J. Clin. Psychopharmacol. (1986) 6:144-149.
22. CROFT H, SETTLE E Jr, HOUSER T, BATEY SR, DONAHUE RM, ASCHER JA: A placebo-controlled comparison of the antidepressant efficacy and effects on sexual functioning of sustained-release bupropion and sertraline. Clin. Ther. (1999) 21:643-658.
23. MICHELSON D, SCHMIDT M, LEE J, TEPNER R: Changes in sexual function during acute and six-month fluoxetine therapy: a prospective assessment. J. Sex Marital Ther. (2001) 27:289-302.
24. CLAYTON AH, ZAJECKA J, FERGUSON JM, FILIPIAK-REISNER JK, BROWN MT, SCHWARTZ GE: Lack of sexual dysfunction with the selective noradrenaline re-uptake inhibitor reboxetine during treatment for major depressive disorder. Int. Clin. Psychopharmacol. (2003) 18:151-156.
25. WATANABE S, YOKOYAMA S, KUBO S, IWAI H, KUYAMA C: A double-blind controlled study of clinical efficacy of maprotiline and amitripryline in depression. Folia Psychiatr. Neurol. Jpn (1978) 32:1-31.
26. PHILIPP MR, KOHNEN R, BENKERT O: A comparison study of moclobemide and doxepine in major depression with special reference to effects on sexual dysfunction. Int. Clin. Psychopharmacol. (1993) 7:123-132.
27. FEIGER A, KIEV A, SHRIVASTAVA RK, WISSELINK PG, WILCOX CS: Nefazodone versus sertraline in out-patients with major depression: focus on efficacy, tolerability and effects on sexual function and satisfaction. J. Clin. Psychiatry (1996) 57(Suppl. 2):S53-S62.
28. KAVOUSSI RJ, SEGRAVES RT, HUGHES AR, ASCHER JA, JOHNSTON JA: Double-blind comparison of bupropion sustained release and sertraline in depressed out-patients. J. Clin. Psychiatr. (1997) 58:532-537.
29. EKSELIUS L, VON KNORRING L, EBERHARD G: A double-blind study comparing sertraline and citalopram in patients with major depression treated in general practice. Eur. Neuropsychopharmacol. (1997) 7:S147.
30. COLEMAN CC, KING BR, BOLDEN-WATSON C et al.: A placebo-controlled comparison of the effects on sexual functioning of bupropion sustained release and fluoxetine. Clin. Ther. (2001) 23:1040-1048.
31. WADE A, CRAWFORD GM, ANGUS M, WILSON R, HAMILTON L: A randomized, double-blind, 24-week study comparing the efficacy and tolerability of mirtazapine and paroxetine in depressed patients in primary care. Int. Clin. Psychopharmacol. (2003) 18:133-141.
32. ZAJECKA J: Strategies for the treatment of antidepressant-related sexual dysfunction. J Clin. Psychiatry (2001) 62(Suppl. 3):35-43.
33. BALDWIN DS, MAYERS AG: Sexual side effects of antidepressant and antipsychotic drugs. Adv. Psychiatr. Treat. (2003) 9:202-210.
34. McCABE MP: Evaluation of a cognitive behaviour therapy programme for people with sexual dysfunction. J. Sex Marital Ther. (2001) 27:259-271.
35. MONTEJO-GONZALEZ AL, LLORCA G, IZQUIERDO JA: SSRI-induced sexual dysfunction: fluoxetine, paroxetine, sertraline, and fluvoxamine in a prospective, multicenter, and descriptive clinical study of 344 patients. J. Sex Marital Ther. (1997) 23:176-194.
36. MONTEJO AL, LLORCA G, IZQUIERDO JA, RICO-VILLADEMOROS F: Incidence of sexual dysfunction associated with antidepressant agents: a prospective multicenter study of 1022 out-patients. Spanish Working Group for the Study of Psychotropic-Related Sexual Dysfunction. J. Clin. Psychiatry (2001) 62(Suppl. 3):10-21.
37. HERMAN JB, BROTMAN AW, POLLACK MH, FALK WE, BIEDERMAN J, ROSENBAUM JF: Fluoxetine-induced sexual dysfunction. J. Clin. Psychiatry (1990) 51:25-27.
38. BENAZZI F, MAZZOLI M: Fluoxetine-induced sexual dysfunction: a dose-dependent effect? Pharmacopsychiatry (1994) 27:246
39. ZAJECKA J, MITCHELL S, FAWCETT J: Treatment-emergent changes in sexual function with selective serotonin re-uptake inhibitors as measured with the Rush Sexual Inventory. Psychopharmacol. Bull. (1997) 33:755-760.
40. ROTHSCHILD AJ: Selective serotonin re-uptake in hibitor-induced sexual dysfunction: efficacy of a drug holiday. Am. J. Psychiatry (1995) 152:514-516.
41. MICHELSON D, BANCROFT J, TARGUM S, KIM Y, TEPNER R: Female sexual dysfunction associated with antidepressant administration: a randomized, placebo-controlled study of pharmacologic intervention. Am. J. Psychiatry (2000) 157:239-243.
42. CLAYTON A, MCGARVEY EL, WARNOCK J, KORNSTEIN SG, PINKERTON RC: Bupropion as an antidote to SSRI-induced sexual dysfunction. 40th Annual NCDEU Meeting. National Institute of Mental Health (2000). Poster 169.
43. MASAND PS, ASHTON AK, GUPTA S, FRANK B: Sustained-release bupropion for selective serotonin re-uptake inhibitor-induced sexual dysfunction: a randomized, double-blind, placebo-controlled, parallel-group study. Am. J. Psychiatry (2001) 158:805-807.
44. BODKIN JA, LASSER RA, WINES JD, GARDNER DM, BALDESSARINI RJ: Combining serotonin re-uptake inhibitors and bupropion in partial responders to antidepressant monotherapy. J. Clin. Psychiatry (1997) 58:137-145.
45. KENNEDY SH, MCCANN SM, MASELLIS M et al.: Combining bupropion SR with venlafaxine, paroxetine or fluoxetine: a preliminary report on pharmacokinetic, therapeutic and sexual dysfunction effects. J. Clin. Psychiatry (2002) 63:181-186.
46. NORDEN MJ: Buspirone treatment of sexual dysfunction associated with selective serotonin re-uptake inhibitors. Depression (1994) 2:109-112.
47. LANDEN M, BJORLING G, AGREN H, FAHLEN T: A randomized, double-blind, placebo-controlled trial of buspirone in combination with an SSRI in patients with treatment-refractory depression. J. Clin. Psychiatry (1998) 59:664-668.
48. BARTLIK BD, KAPLAN HS: Psychostimulants apparently reverse sexual dysfunction secondary to selective serotonin re-uptake inhibitors. J. Sex Marital Ther. (1995) 21:264-271.
49. KANG BJ, LEE SJ, KIM MD, CHO MJ: A placebo-controlled, double-blind trial of Ginkgo biloba for antidepressant-induced sexual dysfunction. Hum. Psychopharmacol. (2002) 17:279-284.
50. NELSON EB, SHAH VN, WELGE JA, KECK PE: A placebo-controlled, crossover trial of granisetron in SRI-induced sexual dysfunction. J. Clin. Psychiatry (2001) 62:469-473.
51. 2 antagonist, in the treatment of sexual dysfunction induced by serotonin re-uptake inhibitors. Clin. Neuropharmacol. (1997) 20:210-214.
52. AIZENBERG D, NAOR S, ZEMISHLANY Z, WEIZMAN A: The serotonin antagonist mianserin for treatment of serotonin re-uptake inhibitor-induced sexual dysfunction in women: an open-label add-on study. Clin. Neuropharmacol. (1999) 22:347-350.
53. DOLBERG OT, KLAG E, GROSS Y, SCHREIBER S: Relief of serotonin selective re-uptake inhibitor induced sexual dysfunction with low-dose mianserin in patients with traumatic brain injury. Psychopharmacology (2002) 161:404-407.
54. MICHELSON D, KOCIBAN K, TAMURA R, MORRISON MF: Mirtazapine, yohimbine or olanzapine augmentation therapy for serotonin re-uptake-associated female sexual dysfunction: a randomized, placebo-controlled trial. J. Psychiatry Res. (2002) 36:147-152.
55. PRICE D: Sildenafil citrate (Viagra) in the treatment of erectile dysfunction in patients with common concomitant conditions. In: Selected Proceedings from the 8th World Meeting of the International Society for Impotence Research. Padma-Nathan H (Ed.), Amsterdam, 24 - 28 August 1996. Int. J. Clin. Pract. (1999) 102:21-23.
56. FAVA M, RANKIN MA, ALPERT JE, NIERENBERG AA, WORTHINGTON JJ: An open trial of sildenafil in antidepressantHinduced sexual dysfunction. Psychother. Psychosom. (1998) 67:328-331.
57. SEIDMAN SN, ROOSE SP, MENZA MA, SHABSIGH R, ROSEN RC: Treatment of erectile dysfunction in men with depressive symptoms: results of a placebo-controlled trial with sildenafil citrate. Am. J. Psychiatry (2001) 158:1623-1630.
58. NURNBERG HG, GELENBERG A, HARGREAVE TB, HARRISON WM, SIEGEL RL, SMITH MD: Efficacy of sildenafil citrate for the treatment of erectile dysfunction in men taking serotonin re-uptake inhibitors. Am. J. Psychiatry (2001) 158:1926-1928.
59. NURNBERG HG, HENSLEY PL: Sildenafil citrate for the management of antidepressant-associated erectile dysfunction. J. Clin. Psychiatry (2003) 64(Suppl. 10):20-25.
60. GARDNER EA, JOHNSTON JA: Bupropion-an antidepressant without sexual pathophysiological action. J. Clin. Psychopharmacol. (1985) 5:24-29.
61. WALKER PW, COLE JO, GARDNER EA et al.: Improvement in fluoxetine-associated sexual dysfunction in patients switched to bupropion. J. Clin. Psychiatry (1993) 54:459-465.
62. GELENBERG AJ, LAUKES C, MCGAHUEY C et al.: Mirtazapine substitution in SSRI-induced sexual dysfunction (abstract). Biol. Psychiatry (1998) 43:104S.
63. KOUTOUVIDIS N, PRATIKAKIS M, FOTIADOU A: The use of mirtazapine in a group of 11 patients following poor compliance to selective serotonin re-uptake inhibitor treatment due to sexual dysfunction. Int. Clin. Psychopharmacol. (1999) 14:253-255.
64. BOYARSKY BK, HAQUE W, ROULEAU MR, HIRSCHFELD RM: Sexual functioning in depressed out-patients taking mirtazapine. Depress. Anxiety (1999) 9:175-179.
65. RAMASUBBU R: Switching to moclobemide to reverse fluoxetine-induced sexual dysfunction in patients with depression. J. Psychiatry Neurosci. (1999) 24:45-50.
66. FERGUSON JM, SHRIVASTAVA RK, STAHL SM et al.: Re-emergence of sexual dysfunction in patients with major depressive disorder: double-blind comparison of nefazodone and sertraline. J. Clin. Psychiatry (2001) 62:24-29.
67. BONIERBALE M, LANCON C, TIGNOL J: The ELIXIR study: evaluation of sexual dysfunction in 4557 depressed patients in France. Curr. Med Res. Opin. (2003) 19:114-124.
68. ATMACA M, KULOGLU M, TEZCAN E, BUYUKBAYRAM A: Switching to tianeptine in patients with antidepressant-induced sexual dysfunction. Hum. Psychopharmacol. (2003) 18:277-280.
69. GOODMAN RE: An assessment of clomipramine (Anafranil) in the treatment of premature ejaculation. J. Int. Med. Res. (1980) 8(Suppl. 3):53-59.
70. KIM SC, SEO KK: Efficacy and safety of fluoxetine, sertraline and clomipramine in patients with premature ejaculation: a double-blind, placebo-controlled study. J. Urol. (1998) 159:425-427.
71. MURAT BASAR M, ATAN A, YILDIZ M, BAYKAM M, AYDOGANLI L: Comparison of sertraline to fluoxetine with regard to their efficacy and side effects in the treatment of premature ejaculation. Archiv. Esp. Urol. (1999) 52:1008-1011.
72. MANASIA P, POMEROL J, RIBE N, GUTIERREZ DEL POZO R, ALCOVER GARCIA J: Comparison of the efficacy and safety of 90 mg versus 20 mg fluoxetine in the treatment of premature ejaculation. J. Urol. (2003) 170:164-165.
73. MCMAHON CG, TOUMA K: Treatment of premature ejaculation with paroxetine hydrochloride as needed: 2 single-blind placebo-con trolled crossover studies. J. Urol. (1999) 161:1826-1830.
74. ROWLAND DL, GOUVEIA BRAZAO CA, KOOS SLOB A: Effective daily treatment with clomipramine in men with premature ejaculation when 25 mg (as required) is ineffective. BJU Int. (2001) 87:357-360.
75. WALDINGER MD, HENGEVELD MW, ZWINDERMAN AH: Ejaculation-retarding properties of paroxetine in patients with primary premature ejaculation: a double-blind, randomized, dose-response study. Br. J. Urol. (1997) 79:592-595.
76. ATAN A, BASAR MM, AYDOGANLI L: Comparison of the efficacy of fluoxetine alone versus fluoxetine plus local lidocaine ointment in the treatment of premature ejaculation. Archiv. Esp. Urol. (2000) 53:856-858.
77. SALONIA A, MAGA T, COLOMBO R et al.: A prospective study comparing paroxerine alone versus paroxetine plus sildenafil in patients with premature ejaculation. J. Urol. (2002) 168:2486-2489.
78. CHEN J, MABJEESH NJ, MATZKIN H, GREENSTEIN A: Efficacy of sildenafil as adjuvant therapy to selective serotonin re-uptake inhibitor in alleviating premature ejaculation. Urology (2003) 61:197-200.
79. McMAHON CG: Presented at European Society for Sexual Medicine, Turkey 2003.
80. YILMAZ U, TATLISEN A, TURAN H, ARMAN F, EKMEKCIOGLU O: The effects of fluoxerine on several neurophysiological variables in patients with premature ejaculation. J. Clin. Psychiatry (1999) 161:107-111.
81. ROWLAND DL, TAI WL, SLOB AK: An exploration of emotional response to erotic stimulation in men with premature ejaculation: effects of treatment with clomipramine. Arch. Sex. Behav. (2003) 32:145-153.
82. ATMACA M, KULOGLU M, TEZCAN E, SEMERCIOZ A: The efficacy of citalopram in the treatment of premature ejaculation: a placebo-controlled study. Int. J. Impot. Res. (2002) 14:502-505.
83. STRASSBERG DS, GOUVEIA BRAZAO CA, ROWLAND DL, TAN P, SLOB AK: Clomipramine in the treatment of rapid (premature) ejaculation. J. Sex Marital Ther. (1999) 25:89-101.
84. BIRI H, ISEN K, SINIK Z, ONARAN M, KUPELI B, BOZKIRLI I: Sertraline in the treatment of premature ejaculation: a double-blind placebo-controlled study. Int. Urol. Nephrol. (1998) 30:611-615.
85. MCMAHON CG: Treatment of premature ejaculation with sertraline hydrochloride: a single-blind placebo-controlled crossover study. J. Urol. (1998) 159:1935-1938.
86. HAENSEL SM, KLEM TM, HOP WC, SLOB AK: Fluoxetine and premature ejaculation: a double-blind, crossover, placebo-controlled study. J. Clin. Psychopharmacol. (1998) 18:72-77.
87. KARA H, AYDIN S, YUCEL M, AGARGUN MY, ODABAS O, YILMAZ Y: The efficacy of fluoxetine in the treatment of premature ejaculation: a double-blind placebo-controlled study. J. Urol. (1996) 156:1631-1632.
88. HAENSEL SM, ROWLAND DL, KALLAN KT: Clomipramine and sexual function in men with premature ejaculation and controls. J. Urol. (1996) 156:1310-1315.
89. WALDINGER MD, HENGEVELD MW, ZWINDERMAN AH: Paroxetine treatment of premature ejaculation: a double-blind, randomized, placebo-controlled study. Am. J. Psychiatry (1994) 151:1377-1379.
90. SEGRAVES RT, SARAN A, SEGRAVES K, MAGUIRE E: Clomipramine versus placebo in the treatment of premature ejaculation: a pilot study. J. Sex Marital Ther. (1993) 19:198-200.
91. GIRGIS SM, EL HAGGAR S, EL HERMOUZY S: A double-blind trial of clomipramine in premature ejaculation. Andrologia (1982) 14:364-368.
92. NAZARETH I, BOYNTON P, KING M: Problems with sexual function in people attending London general practitioners: cross-sectional study. Br. Med. J. (2003) 327:423.
93. MERCER CH, FENTON KA, JOHNSON AM et al.: Sexual function problems and help seeking behaviour in Britain: national probability sample survey. Br. Med. J. (2003) 327:426-427.
94. LABBATE LA, CROFT HA, OLESHANSKY MA: Antidepressant-related erectile dysfunction: management via avoidance, switching antidepressants, antidotes, and adaptation. J. Clin. Psychiatry (2003) 64(Suppl. 10):11-19.
95. CLAYTON AH, PRADKO JF, CROFT HA et al.: Prevalence of sexual dysfunction among newer antidepressants. J. Clin. Psychiatry (2002) 63:357-366.
96. 2C receptor gene polymorphism. Lancet (2002) 359:2086-2087.